(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability
about
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptorsSensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- miceThe endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communicationEmerging drugs of abuse: current perspectives on synthetic cannabinoidsCannabinoids as therapeutic agents in cancer: current status and future implicationsΔ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cellsPharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategiesInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigsMechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteriesDesign and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligandMethanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanismEndothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerolTerpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systemsApparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinolRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationDifferential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brainExpression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspectiveStructural determinants for recognition and translocation by the anandamide transporter.Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytesEndocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.Diuretic effects of cannabinoids.Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout miceCannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeysDissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicleEndocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide.Production and actions of the anandamide metabolite prostamide E2 in the renal medullaCardiovascular pharmacology of cannabinoids.Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity.Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.
P2860
Q24642509-4DC5A8D3-56CD-4BA7-A0A0-8DD7D67873D6Q24647599-312EF172-6760-4586-93DC-A845D61BE20FQ24651338-838D3B00-F793-4ABA-9F8D-E10072B7FB8EQ26778885-B6003094-32B0-49CC-8A78-C55116C53E73Q26866298-CB3F599D-9F55-45FE-A2B7-7CD5CE578F3CQ28238141-37B0C345-393A-4996-A903-06794B3D1DDDQ28241318-9B335779-BAEF-4A7F-9A26-9864080B4F30Q28283718-01886937-B7D3-4A1F-8B75-462DDAEC48F7Q28298445-E553FBE0-972F-4A07-89C3-3EB58340DB95Q28362063-2EC083D0-BDBB-4571-B4C1-6E825FB56A35Q28362103-AA31D2A8-C3D1-448B-8BA7-FFEAE979F2C1Q28366135-4735F42F-D02C-41AD-83C4-A2DA1D45FFF2Q28566274-C71D6853-D02B-4ED7-98D4-609DAADB1914Q28582727-F25C0018-A87F-473A-B383-649411E5DDE1Q28829964-48406D15-BDF1-4ADB-988E-F1FFDD5B62FBQ28833498-4C95C06C-501B-4792-A787-E757251B2409Q30357558-B7A8CFE2-E868-47FD-8858-8BBF3751A858Q33258602-20F7F2AA-E054-476E-85F0-01290F6B3853Q33291748-5981DB80-55B7-42FC-BB24-6CDD7B486552Q33751118-3D8057D4-455B-47BC-8980-8C2BFB946DBAQ33781776-9033D33A-6E9C-4BE2-B782-16EF44AD182DQ33861497-D9A69DFA-3295-470D-B5C3-E6A86072439EQ33929785-75AAC119-BE1A-4A08-B0C0-B76CB77B822CQ33997873-BC2DE1F0-A70C-4F6B-AAF0-8D2E2015BD41Q34066911-921B17D5-DE2C-44AE-8A28-F3001EBA8623Q34181090-C8D622BF-6501-4CA2-8A95-2DA536A496F2Q34302379-B99573B5-2360-405C-B277-23654073F686Q34453695-C4E95300-8C17-4DAE-A829-F32230B1F43EQ34766609-F3911614-B9EB-45F3-8EA0-C58231422B37Q34846838-AA54E91B-39B1-408A-949E-A1844A4BE5A8Q35070299-143658FB-F9DC-4DD2-A4F3-5A1706144FEBQ35162907-94E1030D-DCA3-4D52-9BC1-D008D5B9322CQ35228889-9B137783-20C5-4D5D-AD7E-3D008D1E2490Q35564284-BA361771-137C-49EA-8E8D-855C9431F862Q35684044-8E2F5CDA-15F5-4A1D-BE19-89C459155A7EQ36057140-9EC8D74E-E3FE-4DC7-BC83-A04DC6579A88Q36174214-9EBD8730-6598-40AC-A3DE-2C6540C33323Q36431860-E146ACD8-A63D-4C59-A6B9-AC70AA290DB9Q36451585-8B4097B3-32F8-46C5-91ED-68F3E8DE8B56Q36775155-3FA327AE-FF91-4950-A82B-88DA7F472C98
P2860
(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@ast
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@en
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@nl
type
label
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@ast
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@en
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@nl
prefLabel
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@ast
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@en
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@nl
P2093
P356
P1476
(R)-methanandamide: a chiral n ...... otency and metabolic stability
@en
P2093
P304
P356
10.1021/JM00038A020
P407
P577
1994-06-10T00:00:00Z